Percutaneous absorption accelerator and preparation containing same
June 2, 2009. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3666671 Process and composition for the production of suppositories Stable insulin preparation for nasal administration Composition and method for making a suppository for introducing a hypoglycemic agent into a mammal Antiinflammatory analgesic gelled ointment Pharmaceutical preparations Pharmaceutical preparations Pharmaceutical preparations Use of eucalyptol for enhancing skin permeation of bio-affecting agents Pharmaceutical composition for the treatment of diabetes mellitus InventorsAssigneeApplicationNo. 361489 filed on 06/02/1989US Classes:424/436, Anal, rectal (e.g., suppositories, etc.)424/45, Organic pressurized fluid424/47, Topical live body grooming or adorning aid (e.g., hair spray, antiperspirant, etc.)424/433, Depot, pellet, matrix, or suppository424/434, Mucosal (e.g., nasal, etc.)424/435, Mouth424/443, Web, sheet or filament bases; compositions of bandages; or dressings with incorporated medicaments424/444, Resorbable by the body424/449, Transdermal or percutaneous514/3, Insulin or derivative514/4, With an additional active ingredient514/165, Aspirin per se (i.e., 2-(acetyloxy)benozic acid)514/946, PENETRANT OR ABSORBENT (ENHANCES PENETRATION INTO SUBJECT TREATED)514/947Topical applicationExaminersPrimary: Page, Thurman K.Assistant: Spear, James M. Attorney, Agent or FirmForeign Patent References
International ClassA61K 009/02Foreign Application Priority Data1984-04-23 JPAbstractA percutaneous absorption accelerator and a percutaneous absorbent preparation containing the same and, more particularly, a percutaneous absorption accelerator containing either derivatives of specific glycerols or polyglycerols and alcohols as effective components and a percutaneous absorbent preparation containing the percutaneous absorption accelerators and pharmaceutically effective components.Other References
Field of SearchDepot, pellet, matrix, or suppositoryMucosal (e.g., nasal, etc.) Mouth Anal, rectal (e.g., suppositories, etc.) Transdermal or percutaneous Insulin or derivative With an additional active ingredient Aspirin per se (i.e., 2-(acetyloxy)benozic acid) PENETRANT OR ABSORBENT (ENHANCES PENETRATION INTO SUBJECT TREATED) Topical application | |
